| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology,...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Protagonist Therapeutics (NASDAQ:PTGX) through any online brokerage.
Other companies in Protagonist Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Protagonist Therapeutics has a consensus price target of $128.71.
The stock price for Protagonist Therapeutics (NASDAQ: PTGX) is $141 last updated October 2, 2026 at 4:26 PM EDT.
There are no upcoming dividends for Protagonist Therapeutics.
Protagonist Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Protagonist Therapeutics.
Protagonist Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
